Joshi, J., Tanner, L., Gilchrist, L., & Bostrom, B. (2019). Switching to Bortezomib may Improve Recovery From Severe Vincristine Neuropathy in Pediatric Acute Lymphoblastic Leukemia. Journal of pediatric hematology/oncology, 41(6), 457. https://doi.org/10.1097/MPH.0000000000001529
Chicago Style (17th ed.) CitationJoshi, Jaitri, Lynn Tanner, Laura Gilchrist, and Bruce Bostrom. "Switching to Bortezomib May Improve Recovery From Severe Vincristine Neuropathy in Pediatric Acute Lymphoblastic Leukemia." Journal of Pediatric Hematology/oncology 41, no. 6 (2019): 457. https://doi.org/10.1097/MPH.0000000000001529.
MLA (9th ed.) CitationJoshi, Jaitri, et al. "Switching to Bortezomib May Improve Recovery From Severe Vincristine Neuropathy in Pediatric Acute Lymphoblastic Leukemia." Journal of Pediatric Hematology/oncology, vol. 41, no. 6, 2019, p. 457, https://doi.org/10.1097/MPH.0000000000001529.